APA (7th ed.) Citation

N, H., R, O., D, K., Y, F., Y, S., R, H., . . . K, Y. (2026). Long-term outcome of nimustine-based chemotherapy for oligodendroglioma. Neuro-oncology advances, 8(1), vdag025. https://doi.org/10.1093/noajnl/vdag025

Chicago Style (17th ed.) Citation

N, Hata, et al. "Long-term Outcome of Nimustine-based Chemotherapy for Oligodendroglioma." Neuro-oncology Advances 8, no. 1 (2026): vdag025. https://doi.org/10.1093/noajnl/vdag025.

MLA (9th ed.) Citation

N, Hata, et al. "Long-term Outcome of Nimustine-based Chemotherapy for Oligodendroglioma." Neuro-oncology Advances, vol. 8, no. 1, 2026, p. vdag025, https://doi.org/10.1093/noajnl/vdag025.